William Ciambrone
Director/Board Member chez Massachusetts Biotechnology Education Foundation
Fortune : 1 M $ au 31/03/2024
Profil
William F.
Ciambrone is currently the Director at Massachusetts Biotechnology Education Foundation.
Previously, he held the position of Executive Vice President-Technical Operations at Sarepta Therapeutics, Inc. from 2019 to 2022 and at Shire Plc from 2013 to 2015.
He also served as Vice President-Quality at Shire Human Genetic Therapies, Inc. Mr. Ciambrone obtained his undergraduate degree from St. Anselm College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/04/2023 | 8 509 ( 0,01% ) | 1 M $ | 31/03/2024 |
Postes actifs de William Ciambrone
| Sociétés | Poste | Début |
|---|---|---|
Massachusetts Biotechnology Education Foundation
 Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Anciens postes connus de William Ciambrone
| Sociétés | Poste | Fin |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 31/12/2022 |
| SHIRE | Corporate Officer/Principal | 01/08/2015 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | 01/01/2005 |
Formation de William Ciambrone
| St. Anselm College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
Massachusetts Biotechnology Education Foundation
Massachusetts Biotechnology Education Foundation Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Education Foundation supports science and biotechnology education in Massachusetts through school programs and workforce training. The company was founded in 2001 and is headquartered in Cambridge, MA. | Commercial Services |
